Treatment of aortoiliac occlusive disease: Medical versus endovascular versus surgical therapy

被引：10

作者：

Moise M.A. ^{[1
]}

Kashyap V.S. ^{[1
,2
]}

机构：

[1] Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, 9500 Euclid Avenue

[2] Division of Vascular Surgery and Endovascular Therapy, University Hospitals, Case Medical Center, Cleveland, OH 44106, 11100 Euclid Ave

来源：

Current Treatment Options in Cardiovascular Medicine | 2011年 / 13卷 / 2期

关键词：

Peripheral Arterial Disease; Cilostazol; Critical Limb Ischemia; Intermittent Claudication; Endovascular Therapy;

D O I：

10.1007/s11936-011-0117-x

中图分类号：

学科分类号：

摘要：

Opinion Statement: Aortoiliac occlusive disease (AIOD) is an insidious, progressive atherosclerotic process that can lead to claudication, rest pain, tissue loss, and eventual lower extremity amputation. The patient with AIOD is also at risk for both fatal and nonfatal cardiovascular events. Treatment of the disease includes both risk factor modification and efforts to improve blood flow to the lower extremity. For mild to moderate intermittent claudication, medical therapy as well as a supervised exercise program is advised. For debilitating claudication or critical limb ischemia, a number of recent studies support an endovascular approach for patients with AIOD, citing patency rates that compare favorably to open surgery. Surgical revascularization, however, should still be considered in selected patients. © 2011 Springer Science+Business Media, LLC.

引用

页码：114 / 128

页数：14

共 46 条

[31]

Bendermacher B.L., Willigendael E.M., Teijink J.A., Prins M.H., Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication, Cochrane Database Syst Rev., APR 19, 2, (2006)

[32]

Treesak C., Kasemsup V., Treat-Jacobson D., Nyman J.A., Hirsch A.T., Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease, Vascular Medicine, 9, 4, pp. 279-285, (2004)

[33]

Greenhalgh R.M., Belch J.J., Brown L.C., The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: Results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease, Eur J Vasc Endovasc Surg, 36, 6, pp. 680-8, (2008)

[34]

Murphy T.P., Hirsch A.T., Ricotta J.J., Et al., CLEVER investigators. The CLEVER (Claudication: Exercise Vs. Endoluminal Revascularization) Study: Rationale and Methods, J Vasc Surg, 47, 6, pp. 1356-1363, (2008)

[35]

Caixeta A., Mehran R., Evidence-based management of patients undergoing PCI: Contrast-induced acute kidney injury, Catheter Cardiovasc Interv, 75, SUPPL. 1, pp. 15-20, (2010)

[36]

Brown J.R., Block C.A., Malenka D.J., Et al., Sodium bicarbonate plus N-acetylcysteine prophylaxis: A meta-analysis, JACC Cardiovasc Interv, 2, 11, pp. 1116-24, (2009)

[37]

Upchurch Jr. G.R., Dimick J.B., Wainess R.M., Eliason J.L., Henke P.K., Cowan J.A., Eagleton M.J., Srivastava S.D., Stanley J.C., Diffusion of new technology in health care: The case of aorto-iliac occlusive disease, Surgery, 136, 4, pp. 812-818, (2004)

[38]

Leville C.D., Kashyap V.S., Clair D.G., Bena J.F., Lyden S.P., Greenberg R.K., O'Hara P.J., Sarac T.P., Ouriel K., Endovascular management of iliac artery occlusions: Extending treatment to TransAtlantic Inter-Society Consensus class C and D patients, Journal of Vascular Surgery, 43, 1, pp. 32-39, (2006)

[39]

Klonaris C., Katsargyris A., Tsekouras N., Alexandrou A., Giannopoulos A., Bastounis E., Primary stenting for aortic lesions: From single stenoses to total aortoiliac occlusions, Journal of Vascular Surgery, 47, 2, pp. 310-317, (2008)

[40]

Kashyap V.S., Pavkov M.L., Bena J.F., Et al., The management of severe aortoiliac occlusive disease: Endovascular therapy rivals open reconstruction, J Vasc Surg, 48, 6, pp. 1451-7, (2008)

← 1 2 3 4 5 →